Brain+ A/S: BioStock: Brain+ CEO - "CST is becoming the standard in dementia care"
Brain+ is a health tech company focused on treatment and management of dementia. Centred around Cognitive Stimulation Therapy, the company's approach has the potential to revolutionize dementia care. CEO Kim Baden-Kristensen stopped by the BioStock Studio to talk about Brain+'s path-to-market and the future of dementia management.
Watch the interview with Brain+`s CEO Kim Baden-Kristensen at biostock.se:
Brain+ CEO: "CST is becoming the standard in dementia care" - BioStock (https://www.biostock.se/2024/06/brain-ceo-cst-is-becoming-the-standard-in-dementia-care/)
This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/en/